TERBINAFORCE TABLET

About

TERBINAFORCE TABLET contains Terbinafine, an allylamine antifungal agent. It exerts its fungicidal action by selectively inhibiting squalene epoxidase, a key enzyme in the fungal ergosterol biosynthesis pathway. This inhibition leads to an accumulation of squalene within the fungal cell and a deficiency of ergosterol, both of which are toxic to the fungal cell membrane. The disruption of the cell membrane integrity and function ultimately results in fungal cell death. Terbinafine is particularly effective against dermatophytes, the fungi responsible for various skin, hair, and nail infections, and is well-absorbed orally, allowing for systemic treatment of stubborn mycoses.

Uses

• Treatment of onychomycosis (fungal nail infections)
• Management of tinea corporis (ringworm of the body)
• Treatment of tinea cruris (jock itch)
• Alleviation of tinea pedis (athlete's foot)

Directions For Use

Take one tablet orally once daily, with or without food, for the duration prescribed by your doctor. Complete the full course of treatment.

Benefits

• Highly effective against dermatophyte infections
• Fungicidal action (kills fungi)
• Good penetration into skin, hair, and nails
• Convenient once-daily dosing
• Long-lasting effects after treatment cessation
• Oral administration for systemic infections

Side Effects

• Headache
• Nausea
• Diarrhea
• Abdominal pain
• Indigestion
• Rash
• Itching
• Taste disturbance (dysgeusia)
• Elevated liver enzymes
• Joint pain
• Muscle pain
• Hair loss (rare)

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may increase the risk of liver damage when taken with Terbinafine.
• Pregnancy - Generally not recommended during pregnancy due to limited data. Use only if the potential benefit justifies the potential risk to the fetus, after consulting a doctor.
• Breastfeeding - Terbinafine passes into breast milk. Avoid breastfeeding during treatment.
• Liver - Contraindicated in patients with chronic or active liver disease. Liver function tests should be performed before and during treatment.
• Kidney - Use with caution in patients with renal impairment. Dose reduction may be necessary in severe cases.
• Lung - No specific safety concerns related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.